Shopping Cart

Your shopping cart is currently empty

PHGDH-IN-3

Name: PHGDH-IN-3
Brand: TargetMol
SKU: T73143
Price: 98 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T73143Cas No. 2893778-31-7

PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 2.8 μM against PHGDH, and it can be used in cancer research.

PHGDH-IN-3

😃Good

Purity: 99.1%

Catalog No. T73143Cas No. 2893778-31-7

PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 2.8 μM against PHGDH, and it can be used in cancer research.

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$98	In Stock	In Stock
5 mg	$239	In Stock	In Stock
10 mg	$355	In Stock	In Stock
25 mg	$569	In Stock	In Stock
50 mg	$762	In Stock	In Stock
100 mg	$987	In Stock	In Stock
500 mg	$1,980	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.

Questions

Batch Information

Select Batch

Purity:99.1%

Appearance:Solid

Color:White

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 2.8 μM against PHGDH, and it can be used in cancer research.
Targets&IC50	PHGDH:2.8 μM, PHGDH:2.33 μM
In vitro	PHGDH-IN-3 (compound D8) exhibits strong enzymatic inhibitory activity with an IC50 value of 2.8 μM and demonstrates high binding affinity for PHGDH protein with a Kd value of 2.33 μM. It is particularly effective against cell lines with amplified or overexpressed PHGDH genes and restricts de novo serine synthesis from glucose in MDA-MB-468 cells.[1]
In vivo	PHGDH-IN-3 (compound D8) (1, 3 mg/kg; p.o., i.v.) exhibits excellent in vivo pharmacokinetic properties.[1] Additionally, PHGDH-IN-3 (12.5, 25, 50 mg/kg; i.p.; once daily for 31 days) demonstrated significant antitumor effects in a PC9 xenograft mouse model.[1]

Chemical Properties

Molecular Weight	495.55
Formula	C₂₄H₁₈FN₃O₄S₂
Cas No.	2893778-31-7
Smiles	N(C(=O)C1=CC=C(S(NC2=CC(C(C)=O)=CC=C2)(=O)=O)C=C1)C3=NC(=CS3)C4=CC(F)=CC=C4

Storage & Solubility Information

Storage

store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 90 mg/mL (181.62 mM), Sonication and heating to 70℃ are recommended.

In Vivo Formulation

10% DMSO+90% Corn Oil: 5 mg/mL (10.09 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.0180 mL	10.0898 mL	20.1796 mL	100.8980 mL
5 mM	0.4036 mL	2.0180 mL	4.0359 mL	20.1796 mL
10 mM	0.2018 mL	1.0090 mL	2.0180 mL	10.0898 mL
20 mM	0.1009 mL	0.5045 mL	1.0090 mL	5.0449 mL
50 mM	0.0404 mL	0.2018 mL	0.4036 mL	2.0180 mL
100 mM	0.0202 mL	0.1009 mL	0.2018 mL	1.0090 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc